关键词：癫痫；特征；大脑抑制；兴奋信号；不当平衡；反复发作
摘 要：Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Epilepsy: An overview

PART 05: Pipeline analysis

PART 06: Key buying criteria for anti-epileptic drugs

PART 07: Market landscape

Market overview

Five forces analysis

PART 08: Market segmentation by generation of drugs

First-generation anti-epileptic drugs

Second-generation anti-epileptic drugs

Third-generation anti-epileptic drugs

PART 09: Market segmentation by spectrum of activity

Narrow-spectrum anti-epileptic drugs

Broad-spectrum anti-epileptic drugs

PART 10: Market segmentation by type of seizures

Partial onset seizures

Generalized seizures

PART 11: Geographical segmentation

Global epilepsy drugs market by geography 2016-

2020

Epilepsy drugs market in Americas

Epilepsy drugs market in US

Epilepsy drugs market in EMEA

Epilepsy drugs market in APAC

Epilepsy drugs market in Japan

Epilepsy drugs market in Australia

Epilepsy drugs market in China

Epilepsy drugs market in India

PART 12: Market drivers

Tentative approval of late-stage pipeline molecules

Special regulatory designations

Development of novel therapeutics using innovative

technologies

PART 13: Impact of drivers

PART 14: Market challenges

Social stigma associated with epilepsy

Growing use of seizure management devices is a threat

to drug therapies

Gradual decrease in incentives/investment by vendors

for new drug development

PART 15: Impact of drivers and challenges

PART 16: Market trends

Development of devices and smartphone apps to detect

seizures and track medications

Reformulation of marketed drugs

Increased uptake of new-generation drugs

PART 17: Vendor landscape

Competitive scenario

Key news

PART 18: Key vendor analysis

Eisai

GSK

Pfizer

UCB

Other prominent vendors

PART 19: Appendix

List of abbreviations

PART 20: Explore Technavio